VYNE - VYNE Therapeutics Non-GAAP EPS of -$2.82 revenue of $0.14M beats by $0.09M August, 14 2023 09:32 AM VYNE Therapeutics Inc Com 2023-08-14 09:32:28 ET VYNE Therapeutics press release ( NASDAQ: VYNE ): Q2 Non-GAAP EPS of -$2.82. Revenue of $0.14M (+7.7% Y/Y) beats by $0.09M . For further details see: VYNE Therapeutics Non-GAAP EPS of -$2.82, revenue of $0.14M beats by $0.09M